688016.SS SHH
Shanghai MicroPort Endovascular MedTech Co., Ltd.
1W: -0.1%
1M: -3.9%
3M: -5.5%
YTD: -13.7%
1Y: -22.0%
3Y: -23.6%
5Y: -61.2%
¥85.48 ($12.75)
+1.64 (+1.96%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$0
-100.0% ▼
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
$0
-100.0% ▼
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$2.1B
-130.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $314M | $352M | $492M | $493M | $563M |
| Depreciation & Amort. | $24M | $33M | $35M | $50M | $0 |
| Stock-Based Comp. | $4M | $16M | $0 | $0 | $0 |
| Change in Working Capital | -$35M | -$81M | -$209K | -$119M | $0 |
| Other Non-Cash Items | $572K | $9M | $62M | -$50M | -$563M |
| Operating Cash Flow | $300M | $334M | $571M | $374M | $0 |
| — Investing Activities — | |||||
| Capital Expenditures | -$90M | -$294M | -$190M | -$213M | $0 |
| Acquisitions (Net) | $35M | -$133M | $0 | -$464M | $0 |
| Investment Purchases | -$1.4B | -$2.5B | -$1.6B | -$4.8B | $0 |
| Investment Sales | $1.4B | $2.6B | $1.6B | $4.7B | $0 |
| Other Investing | -$35M | -$26M | $23M | $11M | $0 |
| Investing Cash Flow | -$75M | -$440M | -$177M | -$733M | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $2M | -$2M | $14M | $0 |
| Stock Repurchased | $0 | $0 | $0 | -$120M | $0 |
| Dividends Paid | -$65M | -$151M | -$166M | -$450M | $0 |
| Other Financing | $25M | -$11M | $1.8B | $21M | $0 |
| Financing Cash Flow | -$40M | -$160M | $1.6B | -$535M | $0 |
| Net Change in Cash | $186M | -$266M | $2.0B | -$894M | -$2.1B |
| Cash End of Period | $1.2B | $971M | $3.0B | $2.1B | $0 |
| Free Cash Flow | $211M | $40M | $368M | $161M | $0 |